Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title
Sort descending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
Release Date:
|
Education | Hospital | All | |
Improving the Equity and Quality of Cancer Care in Colombia
Release Date:
Partner: The Colombian Association of Oncology and Hematology (ACHO)
|
Quality Improvement | Oncology | Colombia | |
Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care
|
Research | Oncology | USA | |
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
|
Quality Improvement | Rare Disease | Canada | |
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
|
Research | Rare Disease | Australia, Canada, France, Germany, Italy, Japan, Korea, Spain | |
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
|
Education | Rare Disease | USA | |
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
|
Quality Improvement | Oncology | Canada | |
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
|
Education | Health Equity | China | |
Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism
|
Education | Internal Medicine | All | |
2024 IM US Headache Medicine Fellowship
Release Date:
|
Fellowship | Internal Medicine | USA | |
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
|
Quality Improvement | Oncology | Spain |
| Title
Sort descending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Cardiac Transthyretin Amyloid (ATTR) Fellowship
Release Date:
Partner: International Society of Amyloidosis
|
Fellowship | Rare Disease | All | |
Extension Grant
Release Date:
|
||||
Bacterial Infections
Release Date:
|
||||
Antimicrobial Stewardship
Release Date:
|
||||
Non-Small Cell Lung Cancer
Release Date:
|
||||
Oncology Educational Needs Assessments
Release Date:
|
||||
Chronic Pain
Release Date:
|
||||
Opioid Pain
Release Date:
|
||||
Cardiovascular Risk in Rheumatoid Arthritis
Release Date:
|
||||
Appropriate Immunizations in Rheumatoid Arthritis Patients
Release Date:
|
||||
Smoking Cessation
Release Date:
|
||||
Pneumococcal Disease Prevention
Release Date:
|